Life sciences · Journal article
Academic Journal of Health Sciences · October 16, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Pediatric ketamine/esketamine research spans anesthesia, sedation, analgesia, and, more recently, psychiatry. By integrating both clinical domains within a single pediatric corpus, this study compared their relative temporal and thematic positions and mapped the intellectual and collaborative structure of the combined field. Methods: Web of Science Core Collection and Scopus were searched through August 2026. After deduplication and eligibility screening, 1,152 English-language articles and reviews published between 1969 and 2026 were analyzed using performance analysis, science mapping, Bradford’s and Lotka’s laws, and latent Dirichlet allocation (LDA) topic modeling. Results: The corpus comprised 4,502 authors, 461 journals, and 27,607 citations; 61.8% of publications appeared during 2011–2026. Anesthesia–sedation–analgesia dominated the historical and thematic structure, with seven LDA topics accounting for 86.8% of dominant assignments. The psychiatry-related topic, centered on adolescent depression and esketamine, was dominant in 3.0% of publications overall, while its mean topic share increased to approximately 10% in the partial 2024–2026 period; the latter estimate is provisional pending complete indexing. Co-citation and bibliographic coupling analyses indicated a shared knowledge base, whereas author collaboration remained sparse and fragmented. Conclusions: Pediatric ketamine/esketamine research has evolved from an established anesthesia–sedation–analgesia base toward more specialized clinical questions, while psychiatry remains a smaller but rapidly expanding domain. However, increasing bibliometric visibility in pediatric psychiatry should not be equated with clinical efficacy or maturity of the evidence base; larger, longer-term multicenter studies are needed to establish efficacy, safety, functional and cognitive outcomes, and developmental effects.